Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I A Cooper

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A randomised double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapyI N Olver, M Wolf, C Laidlaw, et al.
Cancer|July 15, 1988
Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in Hodgkin's disease. An analysis of long-term follow-upI N Olver, M M Wolf, D Cruickshank, et al.
Leukemia & Lymphoma|July 31, 1998
Prognostic markers of disease activity in Hodgkin's diseaseA J Martinow, K Yuen, I A Cooper, et al.
Cancer Treatment Reports|November 1, 1987
Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapyJ F Bishop, M Wolf, J P Matthews, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazineJ F Bishop, I N Olver, M M Wolf, et al.
Journal of Clinical Pathology|September 1, 1986
DNA ploidy patterns and cytokinetics of non-Hodgkin's lymphomaS K Juneja, I A Cooper, G S Hodgson, et al.
Australian and New Zealand Journal of Medicine|April 1, 1983
Mantel irradiation for stage I and stage II Hodgkin's disease--results of a 10 year experienceK H Liew, J C Ding, J P Matthews, et al.
Blood|February 1, 1988
Clinical factors influencing the efficacy of pooled platelet transfusionsJ F Bishop, K McGrath, M M Wolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma GroupI A Cooper, M M Wolf, T I Robertson, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
A randomised double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapyI N Olver, M Wolf, C Laidlaw, et al.
Cancer|July 15, 1988
Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in Hodgkin's disease. An analysis of long-term follow-upI N Olver, M M Wolf, D Cruickshank, et al.
Leukemia & Lymphoma|July 31, 1998
Prognostic markers of disease activity in Hodgkin's diseaseA J Martinow, K Yuen, I A Cooper, et al.
Cancer Treatment Reports|November 1, 1987
Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapyJ F Bishop, M Wolf, J P Matthews, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazineJ F Bishop, I N Olver, M M Wolf, et al.
Journal of Clinical Pathology|September 1, 1986
DNA ploidy patterns and cytokinetics of non-Hodgkin's lymphomaS K Juneja, I A Cooper, G S Hodgson, et al.
Australian and New Zealand Journal of Medicine|April 1, 1983
Mantel irradiation for stage I and stage II Hodgkin's disease--results of a 10 year experienceK H Liew, J C Ding, J P Matthews, et al.
Blood|February 1, 1988
Clinical factors influencing the efficacy of pooled platelet transfusionsJ F Bishop, K McGrath, M M Wolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma GroupI A Cooper, M M Wolf, T I Robertson, et al.
Pageof 7